Patent details

EP2525793 Title: Alpha-2 adrenergic agonist having long duration of intraocular pressure-lowering effect

Basic Information

Publication number:
EP2525793
PCT Application Number:
US2011022001
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP117023424
PCT Publication Number:
WO2011091225
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Alpha-2 adrenergic agonist having long duration of intraocular pressure-lowering effect
French Title of Invention:
Agoniste alpha-2-adrénergique ayant un effet de réduction de la pression intra-oculaire de longue durée
German Title of Invention:
Alpha-2 Adrenorezeptor Agonist mit langanhaltender Augeninnendruck senkender Wirkung
SPC Number:

Dates

Filing date:
21/01/2011
Grant date:
05/09/2018
EP Publication Date:
28/11/2012
PCT Publication Date:
28/07/2011
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
05/09/2018
EP B1 Publication Date:
05/09/2018
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
21/01/2019
Expiration date:
21/01/2031
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
29/08/2018
 
 

Name:
ALLERGAN, INC.
Address:
2525 Dupont Drive, Irvine, CA 92612, United States (US)

Inventor

1

Name:
DIBAS, Mohammed I.
Address:
United States (US)

2

Name:
DONELLO, John E.
Address:
United States (US)

3

Name:
GIL, Daniel W.
Address:
United States (US)

Priority

Priority Number:
296912 P
Priority Date:
21/01/2010
Priority Country:
United States (US)

Classification

IPC classification:
A61K 9/00; A61K 9/08; A61K 31/4184; A61P 27/06;

Publication

European Patent Bulletin

Issue number:
201836
Publication date:
05/09/2018
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
31/05/2019 Outgoing Correspondence 1